Astraveus Appoints Microfluidic expert Etienne Fradet as Chief Technical Officer
• Etienne Fradet brings extensive industry expertise and a successful track record in bringing innovative microfluidic technologies to market
• Appointment strengthens Astraveus’ position in the CGT manufacturing field as it looks to develop and commercialise its Lakhesys platform
Paris, France, 31 August, 2023 – Astraveus SAS (“Astraveus” or the “Company”), the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT) manufacturing, today announces the appointment of Etienne Fradet as Chief Technical Officer.
